d97333e2360ebbd971d1dd310cd53ff3

CEFOTAXIME/CEFOTAXIME+CLAVUNALIC ACID (4 UG/ML)

BIOMERIEUX S.A.·II·Colombia INVIMA·Expires February 19, 2029

Device classification

Risk class / Clase de Riesgo: II
Product type (Spanish): REACTIVO DIAGNOSTICO
Product type (English): DIAGNOSTIC REAGENT

Registration information

Analysis ID: d97333e2360ebbd971d1dd310cd53ff3
Expire date: February 19, 2029

Authorized company / Fabricante

Name (Spanish): BIOMERIEUX S.A.
Name (English): BIOMERIEUX S.A.

Product use / Uso del Producto

Spanish

DETERMINACIÓN DE LOS DIFERENTES ANALITOS RELACIONADOS CON MUESTRAS PROCEDENTES DEL ORGANISMO HUMANO

English

DETERMINATION OF THE DIFFERENT ANALYTES RELATED TO SAMPLES FROM THE HUMAN ORGANISM

About this record

Access comprehensive regulatory information for CEFOTAXIME/CEFOTAXIME+CLAVUNALIC ACID (4 UG/ML) (CEFOTAXIME/CEFOTAXIME+CLAVUNALIC ACID (4 UG/ML)) in the Colombia medical device market through Pure Global AI's free database. This II medical device is registered under INVIMA analysis ID d97333e2360ebbd971d1dd310cd53ff3 and manufactured by BIOMERIEUX S.A.. The device was registered on February 19, 2029.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.